You are here
J&J to pay US$2.2b in fines for improper marketing of drug
[NEW YORK] Johnson & Johnson has agreed to pay more than US$2.2 billion in criminal and civil fines to settle accusations that it improperly promoted the anti-psychotic drug Risperdal to older adults, children and people with developmental disabilities, the Justice Department said.
- CALL +65 6388 3838
- EMAIL firstname.lastname@example.org